These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 4415412)

  • 1. Pyrrolo(4,3,2-de)isoquinolines with central nervous system and antihypertensive activities.
    Demerson CA; Philipp AH; Humber LG; Kraml MJ; Charest MP; Tom H; Vávra I
    J Med Chem; 1974 Nov; 17(11):1140-5. PubMed ID: 4415412
    [No Abstract]   [Full Text] [Related]  

  • 2. Restoration of tyramine responses by bretylium, BW392C60, bethanidine and monoamine oxidase inhibitors in reserpine-treated rats.
    Clarke DE
    Br J Pharmacol; 1970 Jan; 38(1):1-11. PubMed ID: 4391732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive and monoamine oxidase inhibitory activity of some derivatives of 3-formyl-4-oxo-4H-pyrido (1,2-a) pyrimidine.
    George T; Kaul CL; Grewal RS; Tahilramani R
    J Med Chem; 1971 Oct; 14(10):913-5. PubMed ID: 4398920
    [No Abstract]   [Full Text] [Related]  

  • 4. 3,4-Dihydroisocarbostyril and 1,2,3,4-tetrahydroisoquinoline derivatives of ephedrine.
    Trepanier DL; Sunder S
    J Med Chem; 1973 Apr; 16(4):342-7. PubMed ID: 4716178
    [No Abstract]   [Full Text] [Related]  

  • 5. On the physiological disposition and possible mechanism of the antihypertensive action of debrisoquin.
    Medina MA; Giachetti A; Shore PA
    Biochem Pharmacol; 1969 Apr; 18(4):891-901. PubMed ID: 5788526
    [No Abstract]   [Full Text] [Related]  

  • 6. Antihypertensive and monoamine oxidase inhibitory activity of 3-amino-2-oxazolidinone (3AO) and its condensation product with 2-substituted-3-formyl-4-oxo-(4H) pyrido(1,2-a)pyrimidines.
    Kaul CL; Grewal RS
    Biochem Pharmacol; 1972 Feb; 21(3):303-16. PubMed ID: 5014489
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthesis and hypotensive properties of tetrahydroisoquinolines.
    Mathison IW; Fowler KC; Morgan PH; Tidwell RR; Peters ER; Wojciechowski NJ; Lawson JW; Hetzer FK
    J Med Chem; 1973 Apr; 16(4):332-6. PubMed ID: 4716177
    [No Abstract]   [Full Text] [Related]  

  • 8. Selective monoamine oxidase inhibitors. 1. Compounds related to 4-aminophenethylamine.
    Florvall L; Ask AL; Ogren SO; Ross SB
    J Med Chem; 1978 Jan; 21(1):56-63. PubMed ID: 22755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of intravenous tyramine and the cold pressor test to help elucidate a possible mechanism of action of a new isoquinoline compound shown to have antihypertensive properties in humans.
    Pocelinko R; Taylor WJ
    Int Z Klin Pharmakol Ther Toxikol; 1969 Jan; 2(1):13-9. PubMed ID: 4896482
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pharmacological and biochemical effects of hydralazine and dihydralazine].
    van Zwieten PA
    Arzneimittelforschung; 1968 Jan; 18(1):79-84. PubMed ID: 4386976
    [No Abstract]   [Full Text] [Related]  

  • 11. [On the pharmacology of new isoquinoline derivatives].
    Leszkovszky GP; Korbonits D
    Pharmazie; 1967 Aug; 22(8):448-51. PubMed ID: 4386723
    [No Abstract]   [Full Text] [Related]  

  • 12. Relationship between CNS depressant and enzyme inhibitory properties of substituted quinazolone 1,3,4-oxadiazoles.
    Barthwal JP; Tandon SK; Agarwal VK; Dixit KS; Parmar SS
    J Pharm Sci; 1973 Apr; 62(4):613-7. PubMed ID: 4698982
    [No Abstract]   [Full Text] [Related]  

  • 13. Influence of disulfiram and sodium diethyldithiocarbamate on pressor response to tyramine in reserpinized rats.
    Szmigielski A
    Acta Physiol Pol; 1974 May; 25(3):257-62. PubMed ID: 4152260
    [No Abstract]   [Full Text] [Related]  

  • 14. Proceedings: Pharmacology of the adrenergic mechanism.
    Pfeifer AK
    J Neural Transm; 1974; Suppl 11(0):163-80. PubMed ID: 4135935
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experimental study of pharmacological properties of nialamide].
    Gilev AP; Terekhina AI; Tarasova EI; Khavronina ZP
    Farmakol Toksikol; 1967; 30(3):328-31. PubMed ID: 4386187
    [No Abstract]   [Full Text] [Related]  

  • 16. [Study of antimonoamine oxidase action and pharmacological properties of 2,3-dihydro-1H-benz[d,e]isoquinoline hydrochloride].
    Gorkin VZ; Tochilkin AI; Andreeva NI; Mashkovskiĭ MD; Zhuravleva GV
    Farmakol Toksikol; 1974; 37(6):651-5. PubMed ID: 4464086
    [No Abstract]   [Full Text] [Related]  

  • 17. Some considerations in the design of substrate and tissue-specific inhibitors of monoamine oxidase.
    Martin YC; Biel JH
    Adv Biochem Psychopharmacol; 1974; 12(0):37-48. PubMed ID: 4417042
    [No Abstract]   [Full Text] [Related]  

  • 18. Central nervous system depressant actions of clonidine and UK-14,304: partial dissociation of EEG and behavioural effects.
    Ashton H; Rawlins MD
    Br J Clin Pharmacol; 1978 Feb; 5(2):135-40. PubMed ID: 619947
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of debrisoquin (Declinax) on adrenergic function and norepinephrine metabolism.
    Horst WD; Gattanell P
    Biochem Pharmacol; 1970 Jul; 19(7):2335-41. PubMed ID: 5520376
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pharmacology of diphenylalkyl-derivatives. IV. Pharmacology of a noradrenaline increasing effect of dephenylpropylamine-amine-derivatives].
    Leszkovszky GP; Tardos L; Lendvai J; Takács K
    Arzneimittelforschung; 1967 Dec; 17(12):1590-5. PubMed ID: 5633110
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.